Furthermore, combining the S-phase-specific chemotherapeutic gemcitabine with CX3CR1 cell ablation resulted in additional attenuation of tumor progression.<h4>Conclusions</h4>CX3CR1-expressing mononuclear cells invade the TME after radiation therapy in a mouse lung cancer model. Here, CX3CR1 is linked to lung carcinoma.